Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
September 2008, Vol 1, No 7
Perspectives
The Governing Dynamics of the Healthcare Universe: Thinking Lagrangian
Robert E. Henry
Read More
Perspectives
Quality in the Pharmacy Environment
Jan E. Berger, MD, MJ
Read More
Practice Management
Delaware's Wellness Program: Motivating Employees Improves Health and Saves Money
Jennifer "J.J" Davis
Stakeholder Perspective
The Lessons from Delaware's Employee Benefits Program
by
F. Randy Vogenberg, PhD, FASHP
Read More
Practice Management
Switching to Generic Antiepileptic Drugs: Growing Concerns
Dalia Buffery, MA, ABD
Read More
Practice Management
The Better Quality Information to Improve Care for Medicare Beneficiaries Project: Exploring Approaches to Physician Performance Measurement
Aucha Prachanronarong, MHS
Stakeholder Perspective
Medicare's Evolution from Passive Payer to Value-Driven Purchaser of Healthcare
by
Kip Piper, MA, FACHE
Read More
Perspectives
Emerging Trends in Outsourcing Healthcare: Medical Tourism
J. Warren Salmon, PhD
Read More
FDA Approvals
Potayto—Potahto? The Meaning of the FDA's "Complete Response" Letters
Mark Senak, JD
Read More
Original Research
Chronic Obstructive Pulmonary Disease: An Overview
John F. Devine, DO, FACP
Stakeholder Perspective
Cost and Quality Issues in COPD Management
by
Paul Anthony Polansky, BSPharm, MBA
Read More
Practice Management
e-Prescribing: Stakeholders Collaborating to Reduce Medication Errors
Read More
Results 1 - 9 of 9